| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234247 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
Use of CIRT is suggested to be effective and safe for retroperitoneal sarcomas. The results obtained with CIRT were a good overall survival rate and local control, notwithstanding the fact that most patients were not eligible for surgical resection and had high-grade sarcomas.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Itsuko M.D., Kenji M.D., Ph.D., Tadashi M.D., Ph.D., Reiko M.D., Ph.D., Shinji M.D., Ph.D., Tohru M.D., Hiroshi M.D., Ph.D., Hisao M.D., Ph.D., Hirohiko M.D., Ph.D.,